1. Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave
- Author
-
Benfante Alida, Principe Stefania, Seminara Gabriele, Cicero Maria Noemi, Incandela Maria, Scichilone Nicola, Durante Carmen, Benfante A., Principe S., Cicero M.N., Incandela M., Seminara G., Durante C., and Scichilone N.
- Subjects
Pulmonary and Respiratory Medicine ,COVID-19, Health-care management, Respiratory symptoms, Severe asthma ,severe asthma ,medicine.medical_specialty ,Telemedicine ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Severe asthma ,Settore MED/10 - Malattie Dell'Apparato Respiratorio ,Phase (combat) ,Article ,Pandemic ,medicine ,Asthmatic patient ,Humans ,Pharmacology (medical) ,Intensive care medicine ,health-care management ,Pandemics ,business.industry ,SARS-CoV-2 ,Biochemistry (medical) ,Patient contact ,respiratory symptoms ,COVID-19 ,Asthma ,Communicable Disease Control ,business - Abstract
SARS-CoV-2 pandemic has contributed to implement telemedicine, allowing clinicians to follow the patient remotely, therefore minimizing the risk of any exposure to positive COVID-19 patients. We summarize the approaches adopted to treat and monitor severe asthmatic patients during the lockdown phase of the pandemic. Our experience supports the strategy that every effort should be made to minimize patient contact with the health-care system, planning a pathway that allows patients to receive appropriate medical care and continue the biological therapies, thus preventing the loss of disease control and acute severe exacerbations.
- Published
- 2021